Categories

Tag: Uncategorized

POLICY/BLOGS: More slack crap from Medpundit exposes the big conservative morality lie

Late last month the NY Times had a pretty horrendous article about a family that was losing its house because it couldn’t pay for all the co-pays and co-insurance for its sick son’s care. I’ve just got round to catching up on my reading and I’m pretty shocked. You might think that someone who’d taken the Hippocratic oath might decide not to pile in on this, but you’d have mistaken the ever blackening stone that Syd at Medpundit seems to have in place of a heart these days.

She decides that the problem is that the family ran up credit card debt. And one of her readers jumps in to!

Sounds like the real problem here might be the credit cards.I get one or two notices of bankruptcy a year concerning my patients. They always list the debt that is to be forgiven along with the creditors, and it’s overwhelmingly credit card debt – the major cards and the local retailers that have their own credit cards. That’s probably true for the general population as well – which is why the Times couldn’t find a better example of people with health insurance going broke because of medical expenses alone. UPDATE: A reader does the math: The $5,000 a year quoted comes out to: $416.67 a month, $13.69 a day, 7% of the household’s income. One mistake people do make in managing their financial affairs is that they fail to readjust their living standards downward to account for unexpected regular expenses (e.g., sell the house and car and downgrade).Or are we so rich now that the idea is that not only should an illness not bankrupt but that you shouldn’t have to skip trips to the mall?

The only problem is that Syd and her reader failed to read the bloody article! Here’s what it said and it is quickly apparent that the expenses connected to the kid’s illness massively exceed their max-out of pocket and the $5000 number, almost certainly because many of these expenses are somehow excluded from their insurance coverage.

Then the bills started coming in. After a week in the hospital, the couple’s share came to $1,100 – not catastrophic, but more than their small savings. They enrolled in a 90-day payment plan with the hospital and struggled to make the monthly installments of nearly $400, hoping that they did not hit any other expenses.

But Zachery, who was eventually found to have an immune system disorder, kept getting sick, and the expense of his treatment – fees for tests, hospitalizations, medicine – kept mounting, eventually costing the family $12,000 to $20,000 a year.

So the cost is not the $5,000 a year. That’s just the co-pay on ONE of his drugs. The rest is between $12 and $20K a year, and the poor bloody father is out working 90 hours a week to make just 68K a year (which for those of you counting at home is under $30K for a regular working week). So somewhere between 17% and 30% of the family’s PRE-tax income was going to these costs. That’s way more than any young family is going to have to spare, unless perhaps they have a high-earning physician bringing home the bacon. So either the Times didn’t do any fact checking (and God knows they have a sorry legacy on checking them when it helps conservative loonies and their issues), or this family was financially destroyed by medical bills despite having some insurance coverage. And "some" is the appropriate word here:

As the family went from one doctor to the next, without a diagnosis of the root problem, the insurance company often questioned the expenses. Why did Zachery need four doctor visits or five rounds of antibiotics for an ailment that most children shook off in a couple of days? Mrs. Dorsett spent days on the phone, often in voice-mail loops, and often long-distance, pleading her case.

"Like when they refused to pay for antibiotics when he had pneumonia" last year, she said. "The antibiotics cost $373, and we didn’t have it. But we couldn’t just not give it to him. I knew the review board would come around eventually, but he needed the medicine right away. Finally the doctor gave us samples."

She managed the expenses, like many people, by constantly applying for new credit cards, rolling the debt from the old cards into the new ones, which usually came with low introductory interest rates. In a good year, they would have the rolling charges on their credit cards down to $5,000 or $6,000, but the charges always went up again.

And how does Syd’s reader really think they should do it?  Their solution: Stop going to the Mall! Of course Syd’s "reader" didn’t get to page two where it showed that they family buys its clothes at yard sales. And don’t bother bringing your plastic into Syd’s office for your co-pay. Syd apparently doesn’t know that you can use credit cards to pay medical bills, and that they charge outrageous interest rates, and that that is likely to be where the debt came from.

"Not only are the bills higher, but the way we pay for care has changed," said Elizabeth Warren, a professor at Harvard Law School and one of the study’s authors. "My mother always carried a bill with the doctor, but every dollar she paid went to principal. Today, the doctor takes a credit card, and a family might be paying that off at extraordinary interest rates. So people may recover physically from major medical injury, but may not recover financially."

So yup we have a nation of over spenders, but I don;t think this family fits the pattern. But the bullshit morality aimed at people with medical problems like this by our conservative brethren is just astounding. And I remind you that this does not go on to anything like this extent in other industrialized countries because they have come to the reasonable position that being sick should not be a financial death sentence.

POLICY: A tax proposal for fairness, but it’ll never make it, WITH UPDATE

Finally a tax proposal I approve of (even though it would hurt me personally). There’s a commission that wants to lower the limit on mortgage tax deductions.  But of course every elected official in California and New York is freaking out about it.

There has to be a way that this iniquitous tax break (and the one on health benefits) can be removed fairly so that those with the highest incomes don’t get most of the benefit. My proposal would be

1) Abolish all tax relief on second homes (currently you can get a deduction for mortgage payments on a second home with a mortgage of up to $1million)

2) Limit the deduction immediately to the interest on a mortgage that’s equivalent to the median house price in the CSMA (large metro area), so that the number would be bigger in San Francisco and New York, and smaller in Kansas, but then reduce that amount by 5% each year, phasing this out over 15-20 years. (Rather than gong straight to a "modest" house price and sticking with that ongoing)

That would immediately take away the advantage for the high income earners and restore some sanity to the housing market, as well as encouraging people to pay down their mortgages rather than borrow more against their homes for yet more consumer spending.  But it wouldn’t be such a radical move that it would kill the housing market overnight and send us into a recession.

But the panel has come out with average costs that clearly ignore the realities on the ground in more expensive states — The new cap would be linked to Federal Housing Administration mortgage limits set county by county each year based on the cost of a "modest” home. Those limits range from $172,632 in low-cost states to $312,895 in the most expensive counties, such as Santa Clara. Around here the median house price is closer to $750,000.

The trick is getting this number to stall so that housing becomes more affordable, the tax iniquity is not just reduced but eliminated altogether, but that it’s one in a way that doesn’t penalize people in more expensive states and wreck the whole plan.

Still it’s amazing to see that this Administration has anything to do with a plan which doesn’t give extra benefits to the very rich.

And of course health benefit tax deductibility is next, as this Managed Care magazine article discusses. Note the extremely sensible comments from Alain Enthoven and Uwe Reinhardt at the end of the article.

UPDATE–An interesting wrinkle suggested by Uwe. If employers had to put the amount they spend on health insurance on the employees’ W2 would they put the average they spend, or what they actually spend per employee?  Anyone who’s bought health insurance knows that a typical small company is quoted the amount per employee, so a 50 yr old person with a family costs a whole lot more than a 20-something single. Of course most employees don’t realize that. But to take this to its logical extreme for self-insured companies,  "premium" costs per se don’t exist. Instead costs are exactly equal to the actual costs of care for each employee. So should their employees see the total amount spent on their care, and then be taxed on that?  If you have a $100,000 hospital stay, should you pay tax on that money? More interesting conundrums to be worked out here too.

PHARMA: What next for DTC regulation? by James Gardner

Those of you following along at home know that big Pharma is trying to get ahead of a suddenly hostile Congress (including Bill Frist turning on them) on the subject of DTC advertising. This week they’re holding hearings on direct-to-consumer promotion of regulated medical products. Joining us from Washington DC as a guest blogger, ********@*****************ve.com“>James Gardner of One to One Interactive shares his observations on today’s hearings. James is an authority on Internet marketing and how the channel should most effectively be used by pharmaceutical and device marketers. As well as sharing his observations, he’ll also be addressing the panel and advocating for the interactive channel to be regulated differently than traditional TV, radio, and print. His agency’s past and current clients include GlaxoSmithKline, Pfizer, Roche, Boston Scientific, Schering/Berlex, and Digene.

Hello, welcome, and a big “thank you” to Matthew for allowing me to share my observations from today’s FDA hearings on direct-to-consumer (DTC) promotion of regulated pharmaceuticals and medical devices. I’m in Washington for the day to address the hearings with a point-of-view on the internet’s role in DTC promotion, but I’m excited to also provide some color commentary.

As some of you surely know, the FDA announced its intention in mid-September to hold a series of public meetings on a range of issues related to DTC marketing. The FDA’s goal, quite clearly, is to develop a new regulatory paradigm for pharmaceutical and device marketers. While the FDA has been down this path before, the political and business environment today seems more conducive than ever to having real change actually happen. In that sense, these hearings could be an important regulatory milestone.

My personal expectation, shared by many (but not all), is that we’ll see several things emerge from this process:

  • Blanket restrictions on several currently popular promotional tactics
  • Significantly clearer guidelines articulated about still-permissible tactics, and
  • Much stiffer consequences for those failing to comply with the letter and spirit of the new rules.

I don’t see an outright ban on DTC promotions happening, although some will certainly advocate for that approach. Indeed, with the DTC promotion envelope continually and aggressively being pushed by adventurous marketers, one could plausibly argue that wholesale change is both inevitable and desirable.

That said, I think cooler heads will prevail and the FDA will choose a path of lesser resistance by instead adopting many of the voluntary guidelines articulated this summer by PhRMA, the industry’s trade group. Most of their proposals were quite sensible and all would serve as a good starting point for the FDA to regain control of the DTC promotion agenda, if nothing else. A pragmatist always, I see some positive change as being better than no change at all.

For those of you new to the world of FDA hearings, here’s what you’re missing:

Clip_image002

There’s a large podium across the front where the first group of FDA panel members are sitting. Below them, on the audience’s left, are additional panel members. Also below them, but to the audience’s right, sit the 3-4 speakers in each “wave” awaiting their turn to address the group. Speakers use a podium on the audience’s right, projecting slides on two very large television screens. If you look closely, you’ll also see that we’re using the National Transportation and Safety Board’s auditorium – hence, their “shield” on the wall behind the podium.

Speakers have 12 minutes to make their case. When their time ends, the moderator thanks them graciously for participating and helps field questions from his colleagues and, time permitting, the audience. Questions from the FDA panel to speakers are obviously allowed, but questions to the panel in return are generally frowned upon.

Kudos to the FDA — it’s all quite well organized. We’re keeping to the agenda and making good progress.

Tomorrow: Thoughts and reactions to Patrick Kelly from Pfizer and speakers from the ASHP, AARP, and other organizations. I’ll also post my presentation with the hope of stimulating some discussion!

QUALITY/POLICY: Vince Kuraitis on Medicare DM

On Friday, November 4th, 10:00 AM – 10:45 AM Pacific (1:00 PM – 1:45 PM Eastern), Vince Kuraitis, Principal. Better Health Technologies and a leading Disease Management guru will be doing an audioconference of this presentation as part of Managed Care OnLine’s (MCOLs) Managing Health Care Costs Web Summit. I’ve seen an advance copy of his presentation and if you are interested in figuring out what  the heck is going on within the Medicare DM experiment that was called CCIP and is now called something else, I suggest that you sign up.

(If you don’t work for a corporation that can pay the freight but are still desperate to see it, Vince might be able to help, so email  me).

BLOGS: Typepad apparently sucks

Typepad apparently has decided to start being unable to handle its traffic, or something. Anyway it just started eating posts, including a long one I just wrote. I hit save. It gave me an error message and a blank slate, I may have time to rewrite it, but with these web-base tools, if it’s gone, it’s probably gone (unlike say Word which tries to recover stuff).

So I may have to follow my post, but moving blog hosts is a total pain.  Anyone got any ideas? (I bet Typepad wishes it had eaten this one!)

HOSPITALS: Friday Night Update by John Pluenneke

When the going gets tough, the tough form a 501(c)(3) tax-exempt non-profit organization.

HealthSouth Corp. founder Richard Scrushy has formed a nonprofit group focusing on churches and religious charities. Richard and Leslie Scrushy Ministries was incorporated in Jefferson County last month.Records list the charity as being based at 2310 Marin Drive, the private company housed on the Scrushy estate in Vestavia Hills.

SAT MORN. CODA: In New Jersey, a poll this week shows Republican Doug Forrester trailing Democrat Jon Corzine by about 10 points in the race for the Governor’s job. That’s a bit of surprise for some people, as analysts had thought the Republicans had a real chance in the state thanks to local disgust over a series of scandals involving corrupt Democrats. Forrester is a PBM man and a part owner of a privately-held benefits company called BeneCard, which is apparently currently having some problems of its own.  Interestingly, in a state where the pharma industry plays a major economic and political role, Corzine has played the pharma card hard – running attack ads which criticize his opponent’s link to the drug industry. This is not a good sign for the GOP …

PHARMA/POLICY: The status quo versus the NHIN

Here’s my FierceHealthcare editorial this morning:

In a little over a week from now, there’s a special election in California with several propositions on the ballot–mostly to do with the political future of Arnold Schwarzenegger. But the two initiatives to do with drug pricing (Props 78 and 79) have seen an out pouring of money, almost all of it from drug companies. Their "Yes on 78, No on 79" commercials have plastered the airwaves, and the non-partisan Healthvote.org shows that by September 29 (i.e. not counting the last 10 days of campaigning) Big Pharma had donated nearly $80m for the joint campaigns, versus less than $2m spent by their opponents in favor of Prop 79.

The pluses or minuses of two propositions in one state are not the point of this editorial. The point is that a powerful piece of the status quo (Big Pharma) is prepared to spend so much to defend itself against what some might argue is a relatively minor attack on their pricing policy in only one state. The logical conclusion is that real reform of our health system, which will by definition require changes to the economics of physicians, hospitals and insurance companies, will meet even more vigorous resistance in defense of the status quo. Optimists who believe that the development of a National Health Information Network will cure healthcare’s problems might do well to note that the amount provided by Congress for that initiative to change the entire health IT system is only a fraction more than the amount Big Pharma’s rustled up for its single issue campaign in California.

HOSPITALS: The specialty hospital party looks like it’s over

Specialty hospitals have made quite a few docs a very tidy penny, (for instance see this debate from the medical hotspot of South Dakota) and there’s been plenty of propaganda from both sides of this debate. But my sense is that the party really is about to end here. Wednesday saw two signal events that confirm my thoughts.

First, an apparently definitive (not that these things are ever definitive in the world of spin that we live in) study from Jean Mitchell in Health Affairs seems to show that the big community hospitals were right all along. Specialty hospitals have been skimming off the healthier wealthier patients, charging Medicare and insurers the most they could and leaving the community hospitals holding the bag. The AHA and its lackeys in Congress have been all over this, hence the moratorium on specialty hospital construction and the soon-to-come reframing of how specialty hospitals get paid (and it won’t be more!).

Now even more confirmation of problems at the biggest kahuna in the specialty hospital pack as MedCath, which had some problems in the past but had seen its stock double over the past year or so, carelessly loses its CEO within 3 weeks of him taking over. Oh and earnings are down and going further down. Now I’m sure this all the fault of the hurricane and they’re not alone–have you seen Tenet’s stock price lately? But clearly things are not going well.

Of course, Medcath has data (represented by its lackeys independent consultants from Lewin) in the same Health Affairs that claims that Mitchell’s methodology is inaccurate, in that she mistakes who is really "owning" these specialty hospitals, and underplays the role of HMOs in shutting out these specialty hospitals from their networks. But they basically say that as doctors are "entrepreneurial" and then say that "we note that physicians’ demands for more clinical autonomy and control over their incomes will not go away if specialty hospitals are ‘banned.’ " In other words, give ’em any fee schedule, rules, organization, whatever, they’re going to find their way around it.

Of course the only way to really fix this is to put the incentives of the payer/insurer and the providers in the same place rather than opposing each other. If Kaiser Permanente had a specialty hospital, then you’d assume they’d figured out that it made financial and medical sense for their entire system. (And I don’t think they do have one). Obviously improved efficiencies are a good thing, but outside out of the pre-paid integrated sector, most of the health care system is engaged in a series of payment games based on figuring out how to stay ahead of the obscure payment code.

So the solution as ever (and I think Medicare is getting there very slowly) is to change the payment rules.  But even that won’t be perfect. But for now, I suspect that the specialty hospital will find itself forgtten in the same health care attic as the physician-owned home infusion center, soon to be joined by the multi-millionaire oncologist.

assetto corsa mods